The three candidate agents retained their similar and highly significant negative scores in this broader analysis ( Table 1 ).
← all excerpts
Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma.
1
—
—
The three candidate agents retained their similar and highly significant negative scores in this broader analysis ( Table 1 ).